Shaban Athuman
/
VPM News
Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
RVA's Got Issues
VPM 60th Anniversary
Virginia News
NPR News
Virginia News
-
Maggie Clemmons is on leave amid review of workplace culture and harassment allegations. -
Retired Army Maj. Gen. Cedric T. Wins' ouster follows pushback on DEI by some conservative alumni.
-
Who’s Dillon, and why does the commonwealth follow his rule?
-
The board initially sought a $43.7M hike over the previous year.
-
Virginia is the only state that requires lawmakers to approve individual payments.
-
The plaque gives context to the sale of enslaved people in the Charlottesville area.
NPR News
-
On the witness stand on Tuesday, the singer at the center of the prosecution's case said that Combs controlled most aspects of her life and career.
-
On Wednesday, Robert F. Kennedy Jr. goes to Capitol Hill to promote and defend his massive overhaul of HHS, and President Trump's plans to change it even more.
-
The health care conglomerate is facing mounting financial problems – and ongoing consumer anger over high costs and denied claims.
-
A former USAID worker has a new mission. She's hoping to connect philanthropists with overseas programs that have lost — or are likely to lose — their U.S. funding.
-
Consumer prices in April were up 2.3% from a year ago, the smallest annual increase in more than four years. Grocery prices fell 0.4%, thanks to a large drop in the price of eggs.
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal